P142 ROS101, a Novel Targeted Methotrexate Prodrug, Selectively Activated by Reactive Oxygen Species (ROS) Shows Reduced Toxicity in Rat CIA Model of Rheumatoid Arthritis

doi 10.1136/annrheumdis-2018-ewrr2019.126
Full Text
Abstract

Available in full text

Date
Authors
Publisher

BMJ Publishing Group Ltd and European League Against Rheumatism


Related search